- Home
- CMRC vs LAB Comparison
CMRC vs LAB Comparison
Compare CMRC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMRC | LAB |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.0M | 449.9M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CMRC | LAB |
|---|---|---|
| Price | $4.33 | $1.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $7.50 | $1.35 |
| AVG Volume (30 Days) | 666.3K | ★ 2.0M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $339,860,000.00 | $169,737,000.00 |
| Revenue This Year | $5.15 | N/A |
| Revenue Next Year | $4.15 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.97 | ★ 79.77 |
| 52 Week Low | $4.14 | $0.92 |
| 52 Week High | $7.69 | $2.25 |
Technical Indicators
Market Signals| Indicator | CMRC | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 36.97 | 59.98 |
| Support Level | $4.46 | $1.43 |
| Resistance Level | $4.61 | $1.51 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 2.88 | 61.40 |
Price Performance
Historical ComparisonAbout CMRC Commerce.com Inc.
Commerce.com Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of its revenue is generated from Americas-U.S.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.